Quantcast

Latest Retinitis pigmentosa Stories

2010-07-14 14:18:11

Scientists from The Vision Centre have reported remarkable progress in developing ways to restore sight to people suffering from age-related vision loss. Non-invasive treatments that enable damaged vision cells to repair themselves are likely to be a common treatment for ageing people within a few years, says Professor Jonathan Stone of The Vision Centre and University of Sydney. "We're at an exciting stage of the research where it is really starting to look possible to reverse vision loss,...

2010-07-07 15:45:15

Japanese team hopes new discovery will aid in creation of therapies for visual, hearing problems It's safe to say that cilia, the hairlike appendages jutting out from the smooth surfaces of most mammalian cells, have long been misunderstood "“ underestimated, even. Not to be confused with their whiplike cousins flagella, which propel sperm, one type of cilia has been known to serve as microscopic conveyor belts. (Picture cilia reaching up like concertgoers supporting a crowd-surfer.)...

2010-06-25 15:11:33

Retinitis pigmentosa affects over one million people worldwide and is manifested by a progressive loss of sight, eventually leading to blindness. Retinitis pigmentosa is a form of inherited retinal degeneration that affects the light-sensitive cells : photoreceptors. Photoreceptors are a special type of neuron which convert light into nervous impulses. These impulses are then processed by the retina and transmitted along the nerve fibres to the brain. There are two types of photoreceptors:...

2010-06-14 13:06:09

A new gene explains variability in symptoms Usher syndrome (USH), an inherited condition involving both hearing and vision loss, is not a simply recessively inherited disease, a scientist will tell the annual conference of the European Society of Human Genetics today (Saturday). Dr. Hanno Bolz, Associate Medical Director of the Bioscientia Centre for Human Genetics, Ingelheim, Germany, and active in teaching and research at the University Hospital of Cologne, will say that his team's research...

2010-06-14 13:01:08

Researchers working toward cure for pigmentosa; other retinal diseases Researchers at the University of Oklahoma Health Sciences Center have found a way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa, giving hope to the estimated 100,000 Americans who suffer from this debilitating disease. The study appears in the Journal of the Federation of American Societies for Experimental Biology (FASEB). The research, led by Muna Naash, Ph.D., at the...

2010-06-03 04:20:00

TOKYO, June 3 /PRNewswire/ -- We are pleased to announce that the Phase II clinical study of UF-021, product name Ocuseva (TM), which we are developing as a therapeutic drug for retinitis pigmentosa (note 1), has been completed. Retinitis pigmentosa is an intractable disease where therapeutic drugs or therapeutic methods have not been established yet. When the disease of retinitis pigmentosa progresses, the visual field narrows irreversibly and furthermore, in the late stage, they may...

f63af4b5b2056807393b1146936ea0411
2010-05-27 07:57:10

Complex tissue structure "“ a first "“ offers hope to millions with degenerative eye disorders UC Irvine scientists have created an eight-layer, early stage retina from human embryonic stem cells, the first three-dimensional tissue structure to be made from stem cells. It also marks the first step toward the development of transplant-ready retinas to treat eye disorders such as retinitis pigmentosa and macular degeneration that affect millions. "We made a complex structure...

2010-05-03 14:52:00

Honored for innovations that improve vision for visually impaired BOSTON, May 3 /PRNewswire-USNewswire/ -- Dr. Eli Peli, a senior scientist at Schepens Eye Research Institute, has been selected by the Society for Information Display for the Otto Schade Prize. Peli will receive the award at a special presentation at the Society's Awards Banquet on May 24, 2010 in Seattle. Peli was chosen "for his many outstanding contributions to vision science and its application to image quality...

15a4a91e4d70473612e4fbc5b0312cd21
2010-04-29 10:42:56

Veterinary vision scientists at the University of Pennsylvania have safely and successfully used a viral vector in targeting a class of photoreceptors of the retina called rods, a critical first step in developing gene therapies for inherited blindness caused by rod degeneration. In this study, the viral vector, or missile that carries the genetic material designed to correct a DNA mutation, was not intended to treat a disease but to demonstrate through the use of a fluorescent protein that a...

2010-04-21 14:47:00

PHILADELPHIA -- Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness. Achromatopsia is a rare autosomal recessive disorder with an estimated prevalence in human beings of about 1 in 30,000 to 50,000. It primarily affects the function of the cone photoreceptors in the retina and serves as a...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.